Il existe 8+ publications pour ce produit.
L’anticorps anti-V beta 5.1,5.2 Monoclonal Souris est utilisé pour la détection de V beta 5.1,5.2 dans des échantillons de Souris. Il a été validé pour FACS.
Aperçu rapide pour V beta 5.1,5.2 anticorps (Biotin) (ABIN2689956)
Antigène
V beta 5.1,5.2
Reactivité
Souris
Hôte
Souris
Clonalité
Monoclonal
Conjugué
Biotin
Application
Flow Cytometry (FACS)
Clone
MR9
Attributs du produit
The MR9-4 antibody reacts with the Vβ 5.1 and Vβ 5.2 T-cell Receptors of strains having the b haplotype (e.g., C57BL) of the Tcrb gene complex. These gene loci are deleted in mice having the a (e.g., C57BR, C57L, SJL, SWR) or c (e.g., RIII) Tcrb haplotype. Vβ5.1 and 5.2 TCR-bearing T lymphocytes are clonally eliminated, either completely or partially, in mice expressing I-E and superantigens encoded by the Mtv-1 (Mls-4a, Mlsc), Mtv-3 (Mlsc), Mtv-8 (Mlsf), Mtv-9 (Etc-1, Mlsf), Mtv-11 (Mlsf), Mtv-13 (Mls-2a, Mlsc), Mtv-27, Mtv44 , and/or Mtv-MAI endogenous provirus (e.g., A, AKR, BALB/c, C3H/He, C58, CBA/Ca, CBA/J, DBA/2, NZB, NZW). Activation of Vβ5 TCR-expressing T cells by this determinant is dependent upon presentation by I-E. Plate-bound MR9-4 antibody activates Vβ5.1 or 5.2 TCR-bearing T cells. This antibody is routinely tested by flow cytometric analysis. Other applications were tested during antibody development only or reported in the literature. Two-color analysis of the expression of Vβ 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with biotin-conjugated MR9-4, PE-conjugated RM4-5 (anti-CD4, Cat. No. 553048/553049), and PE-conjugated 53-6.7 (anti-CD8a, Cat. No. 553032/553033) monoclonal antibodies, followed by Avidin-FITC (Cat. No. 554057). Flow cytometry was performed on a FACScan .
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Conseil sur la manipulation
The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.
Stock
4 °C
Stockage commentaire
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Tomonari, Fairchild, Rosenwasser: "Influence of viral superantigens on V beta- and V alpha-specific positive and negative selection." dans: Immunological reviews, Vol. 131, pp. 131-68, (1993) (PubMed).
Hügin, Vacchio, Morse: "A virus-encoded "superantigen" in a retrovirus-induced immunodeficiency syndrome of mice." dans: Science (New York, N.Y.), Vol. 252, Issue 5004, pp. 424-7, (1991) (PubMed).
Woodland, Happ, Gollob, Palmer: "An endogenous retrovirus mediating deletion of alpha beta T cells?" dans: Nature, Vol. 349, Issue 6309, pp. 529-30, (1991) (PubMed).
Utsunomiya, Kosaka, Kanagawa: "Differential reactivity of V beta 9 T cells to minor lymphocyte stimulating antigen in vitro and in vivo." dans: European journal of immunology, Vol. 21, Issue 4, pp. 1007-11, (1991) (PubMed).
Bill, Kanagawa, Linten, Utsunomiya, Palmer: "Class I and class II MHC gene products differentially affect the fate of V beta 5 bearing thymocytes." dans: The Journal of molecular and cellular immunology : JMCI, Vol. 4, Issue 5, pp. 269-79; discussion 279-80, (1990) (PubMed).
Woodland, Happ, Bill, Palmer: "Requirement for cotolerogenic gene products in the clonal deletion of I-E reactive T cells." dans: Science (New York, N.Y.), Vol. 247, Issue 4945, pp. 964-7, (1990) (PubMed).
Haqqi, Banerjee, Anderson, David: "RIII S/J (H-2r). An inbred mouse strain with a massive deletion of T cell receptor V beta genes." dans: The Journal of experimental medicine, Vol. 169, Issue 6, pp. 1903-9, (1989) (PubMed).
Behlke, Chou, Huppi, Loh: "Murine T-cell receptor mutants with deletions of beta-chain variable region genes." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 83, Issue 3, pp. 767-71, (1986) (PubMed).